Skip to main content

Find Clinical Trials

Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Recruiting

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

NCT03852407

Conditions: Acute Lymphoid Leukemia in Remission, Acute Myeloid Leukemia in Remission, Blood Protein Disorders, +33 more
Locations: ZNA Stuivenberg Antwerp, Belgium

AZ Sint Jan Brugge Bruges, Belgium

IJ Bordet Brussels, Belgium

UZ Brussel Brussels, Belgium

View Trial Details

Recruiting

APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma

NCT04657861

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

NCT05283993

Conditions: Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +44 more
Locations: Peking University First Hospital Beijing, China

View Trial Details

Recruiting

CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases

NCT04662294

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Recruiting

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

NCT04603872

Conditions: Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphocytic Leukaemia Refractory, Blood Protein Disorders, +28 more
Locations: The First Hospital of Zhejiang Medical Colleage Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

NCT04076449

Conditions: Brain Diseases, Cardiovascular Abnormalities, Cardiovascular Diseases, +29 more
Locations: Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China

Peking University International Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients

NCT04025450

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: First Affiliated Hospital, Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Fluciclovine PET/CT in Multiple Myeloma Patients

NCT03966443

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Oslo University Hosptal Oslo, Norway

View Trial Details

Recruiting

Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma

NCT03196414

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: First Affiliated Hospital, Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

NCT03562169

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Aberdeen Royal Infirmary Aberdeen, United Kingdom

Monklands Hospital Airdrie, United Kingdom

University Hospital Ayr Ayr, United Kingdom

Barnsley Hospital Barnsley, United Kingdom

View all 91 locations

View Trial Details